These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 1834812)

  • 1. Technetium-99m-MAG3 versus iodine-123-OIH: renal clearance and distribution volume as measured by a constant infusion technique.
    Prenen JA; de Klerk JM; van het Schip AD; van Rijk PP
    J Nucl Med; 1991 Nov; 32(11):2057-60. PubMed ID: 1834812
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [A comparison of different methods of calculating clearances using 99mTc-mercaptoacetyltriglycine and 123I- or 131I-ortho-iodohippuric acid].
    Keske U; Cordes M; Hosten N; Roll D; Hunger J; Felix R
    Nuklearmedizin; 1990 Jun; 29(3):93-100. PubMed ID: 2144045
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A comparative evaluation of iodine-131 OIH and technetium-99m MAG3 in the study of renal function].
    Di Lorenzo I; Stiglich F; Barbonetti C; Bonomo F; Maspero S; Paini S; Bottinelli G
    Radiol Med; 1990 Apr; 79(4):376-80. PubMed ID: 2143030
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitation of renal function using MAG3.
    Russell CD; Dubovsky EV
    J Nucl Med; 1991 Nov; 32(11):2061-3. PubMed ID: 1834813
    [No Abstract]   [Full Text] [Related]  

  • 5. The difference in clearance between kit-prepared technetium-99m-MAG3 and radioiodinated hippuric acid.
    Bubeck B; Brandau W
    J Nucl Med; 1991 Aug; 32(8):1642-4. PubMed ID: 1831230
    [No Abstract]   [Full Text] [Related]  

  • 6. Estimate of relative function and transit time in renographic studies.
    González A; Ros D; Pavia J
    J Nucl Biol Med (1991); 1994 Sep; 38(3):502-7. PubMed ID: 7865547
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of technetium-99m MAG3 with iodine-131 hippuran by a simultaneous dual channel technique.
    Russell CD; Thorstad B; Yester MV; Stutzman M; Baker T; Dubovsky EV
    J Nucl Med; 1988 Jul; 29(7):1189-93. PubMed ID: 2969040
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimum sample times for single-injection, multisample renal clearance methods.
    Russell CD
    J Nucl Med; 1993 Oct; 34(10):1761-5. PubMed ID: 8410295
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of 99mTc-mercaptoacetyltriglycine and [131I]-o-iodohippurate elimination in perfused rat kidney.
    Trejtnar F; Laznicek M; Laznickova A
    Nucl Med Biol; 2003 Jan; 30(1):45-9. PubMed ID: 12493542
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prospective validation of a single sample technique to determine technetium-99m-MAG3 clearance.
    Taylor A; Corrigan P; Eshima D; Folks R
    J Nucl Med; 1992 Sep; 33(9):1620-2. PubMed ID: 1387682
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical comparison of technetium-99m-EC, technetium-99m-MAG3 and iodine-131-OIH in renal disorders.
    Kabasakal L; Turoğlu HT; Onsel C; Ozker K; Uslu I; Atay S; Cansiz T; Sönmezoğlu K; Altiok E; Isitman AT
    J Nucl Med; 1995 Feb; 36(2):224-8. PubMed ID: 7830118
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radiation dosimetry for technetium-99m-MAG3, technetium-99m-DTPA, and iodine-131-OIH based on human biodistribution studies.
    Stabin M; Taylor A; Eshima D; Wooter W
    J Nucl Med; 1992 Jan; 33(1):33-40. PubMed ID: 1530968
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [99mTc-MAG3 and 131I-OIH in patients with kidney insufficiency and with normal kidneys].
    Keske U; Cordes M; Wilfling M; Hunger J; Hosten N; Gahl G
    Rofo; 1990 Mar; 152(3):287-92. PubMed ID: 2157251
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical comparison of I-131 orthoiodohippurate and the kit formulation of Tc-99m mercaptoacetyltriglycine.
    Taylor A; Ziffer JA; Steves A; Eshima D; Delaney VB; Welchel JD
    Radiology; 1989 Mar; 170(3 Pt 1):721-5. PubMed ID: 2521734
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of protein binding on renal extraction of 131I-OIH and 99mTc-labeled tubular agents.
    Eshima D; Eshima L; Hansen L; Lipowska M; Marzilli LG; Taylor A
    J Nucl Med; 2000 Dec; 41(12):2077-82. PubMed ID: 11138695
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the clearance of technetium-99m MAG3 and iodine-131 OIH.
    Kim CK; Stritzke P; Goldsmith SJ
    J Nucl Med; 1988 Nov; 29(11):1878-9. PubMed ID: 2972816
    [No Abstract]   [Full Text] [Related]  

  • 17. Estimation of technetium-99m-MAG3 renal clearance in children: two gamma camera techniques compared with multiple plasma samples.
    Gordon I; Anderson PJ; Orton M; Evans K
    J Nucl Med; 1991 Sep; 32(9):1704-8. PubMed ID: 1831838
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Animal evaluation of technetium-99m triamide mercaptide complexes as potential renal imaging agents.
    Eshima D; Taylor A; Fritzberg AR; Kasina S; Hansen L; Sorenson JF
    J Nucl Med; 1987 Jul; 28(7):1180-6. PubMed ID: 2955085
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of single-injection multisample renal clearance methods with and without urine collection.
    Russell CD; Dubovsky EV
    J Nucl Med; 1995 Apr; 36(4):603-6. PubMed ID: 7699449
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical assessment of 99mTc-MAG3 scintigraphy for impaired renal function].
    Sato M; Hirayama K; Ishikawa N; Takeda T; Wu J; Itai Y; Kobayashi M; Koyama A
    Kaku Igaku; 1994 Jan; 31(1):75-84. PubMed ID: 8309113
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.